Humacyte, Inc.
HUMANasdaqCIK 1818382HealthcareFiscal year ends Dec 31
Reports and events: 138 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818382-26-000011 |
| 2026-08-1813:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-098152 |
| 2026-08-1220:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-347022 |
| 2026-08-1211:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094440 |
| 2026-07-3121:00 ET | 8-K | 3.01 Delisting notice | 0001104659-26-089281 |
| 2026-07-1321:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-083164 |
| 2026-06-1513:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-073827 |
| 2026-06-1120:43 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-072980 |
| 2026-06-1020:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-072382 |
| 2026-06-0920:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-071862 |
| 2026-06-0520:30 ET | 8-K | 8.01 Other events | 0001104659-26-071000 |
| 2026-05-1320:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221755 |
| 2026-05-0820:30 ET | 8-K | 3.01 Delisting notice | 0001104659-26-057974 |
| 2026-04-2820:52 ET | DEF 14A | Proxy statementPeriod 2026-04-28 | 0001193125-26-187449 |
| 2026-04-2710:01 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-048819 |
| 2026-04-2412:09 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-048164 |
| 2026-03-2720:45 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001818382-26-000004 |
| 2026-03-2410:02 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-033489 |
| 2026-03-1920:33 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-032116 |
| 2026-03-1912:25 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-031780 |
| 2026-01-0916:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-002371 |
| 2025-12-1622:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-121674 |
| 2025-12-1521:52 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-121214 |
| 2025-12-1514:12 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-120915 |
| 2025-11-2622:01 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-25-116476 |
| 2025-11-1221:46 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001818382-25-000132 |
| 2025-11-1212:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109718 |
| 2025-10-1621:25 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-100146 |
| 2025-10-0721:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-097591 |
| 2025-09-1801:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-090963 |
| 2025-08-1121:01 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001818382-25-000125 |
| 2025-08-1111:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-25-000122 |
| 2025-06-1120:08 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001818382-25-000080 |
| 2025-05-2219:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-051950 |
| 2025-05-1321:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001818382-25-000076 |
| 2025-05-1311:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-25-000073 |
| 2025-04-2920:04 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001818382-25-000066 |
| 2025-04-1821:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001818382-25-000061 |
| 2025-03-3120:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001818382-25-000034 |
| 2025-03-2811:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-25-000030 |
| 2025-03-2721:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-028830 |
| 2025-03-2620:48 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-028274 |
| 2025-03-2520:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-027762 |
| 2024-12-2021:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000227 |
| 2024-11-2000:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001818382-24-000210 |
| 2024-11-1821:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-120135 |
| 2024-11-1421:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-119013 |
| 2024-11-0821:13 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001818382-24-000199 |
| 2024-11-0813:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001818382-24-000197 |
| 2024-10-2820:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001818382-24-000192 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.